Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Titel:
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Auteur:
Stelljes, Matthias Middeke, Jan Moritz Bug, Gesine Wagner-Drouet, Eva-Maria Müller, Lutz P Schmid, Christoph Krause, Stefan W Bethge, Wolfgang Jost, Edgar Platzbecker, Uwe Klein, Stefan A Schubert, Jörg Niederland, Judith Kaufmann, Martin Schäfer-Eckart, Kerstin Schaich, Markus Baldauf, Henning Stölzel, Friedrich Petzold, Cathleen Röllig, Christoph Alakel, Nael Steffen, Björn Hauptrock, Beate Schliemann, Christoph Sockel, Katja Lang, Fabian Kriege, Oliver Schaffrath, Judith Reicherts, Christian Berdel, Wolfgang E Serve, Hubert Ehninger, Gerhard Schmidt, Alexander H Bornhäuser, Martin Mikesch, Jan-Henrik Schetelig, Johannes
Verschenen in:
The Lancet. Haematology
Paginering:
Jaargang 11 () nr. 5 pagina's e324-e335
Jaar:
2024
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license